The Careers in Science and Medicine Summer Internship Program (CSM SIP) is the undergraduate component of the Johns Hopkins Initiative for Careers in Science and Medicine (CSM Initiative).  The CSM Initiative seeks to develop scholars from low-income (<200% of the federal poverty level) and educationally under-resourced (most commonly first-generation college or went to, or would have gone to based on their home address, a high school where the majority are also low-income) backgrounds to help them build the accomplishments, skills, network, and support necessary to achieve advanced careers in biomedical, medical, health-related, and STEM professions.

To date, 133 scholars have participated in CSM SIP. Of those who have reached medical or graduate school age, 50% have matriculated into medical or graduate programs, including the Sidney Kimmel Medical College of Thomas Jefferson, Harvard Medical School, Michigan State University, University of North Carolina Chapel Hill and Ohio State University. 5% of CSM SIP scholars have returned to join our DDP program.

If you are interested in applying to the CSM SIP, the application may be found here.

If you would like more information on CSM SIP, please contact Dr. Venkataramana Sidhaye (vsidhay1@jhmi.edu) or Dr. Kathy Wilson (klwilson@jhmi.edu).

If you are interested in helping support the Johns Hopkins Initiative for Careers in Science and Medicine, please contact Sarah Farrell, Director of Development (sfarrell@jhmi.edu) or Kevin McGuire (kmcgui10@jhmi.edu), Sr. Associate Director of Development, Institute for Basic Biomedical Sciences.

News

Example Publications Authored by CSM Scholars

Kwaa AKR, Talana CAG, Blankson JN. Interferon alpha enhances NK cell function and the suppressive capacity of HIV-specific CD8+ T cells. J. Virol. 2019; 93(3): e01541-18. PMID: 30404799

McAdams-DeMarco MA, Ying H, Thomas AG, Warsame F, Shaffer AA, Haugen CE, Garonzik-Wang JM, Desai NM, Varadhan R, Walston J, Norman SP, Segev DL. Frailty, Inflammatory Markers, and Waitlist Mortality Among Patients with End-Stage Renal Disease in a Prospective Cohort Study. Transplantation. 2018; 102(10):1740-1746. PMID: 29677074

Osman G, Rodriguez J, Chan SY, Chisholm J, Duncan G, Kim N, Tatler AL, Shakesheff KM, Hanes J, Suk JS, Dixon JE. PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy. J Control Release. 2018; 285:35-45.  PMID: 30004000.

Chavez-Valdez R, Emerson P, Goffigan-Holmes J, Kirkwood A, Martin LJ, Northington FJ. Delayed injury of hippocampal interneurons after neonatal hypoxia-ischemia and therapeutic hypothermia in a murine model. Hippocampus. 2018;  28(8):617-630.  PMID: 29781223.

Perez-Dulzaides R, Camacho E, Cordero RJB, Casadevall A. Cell-wall dyes interfere with Cryptococcus neoformans melanin deposition. Microbiology. 2018; 164(8):1012-1022. PMID: 29939127.

McAdams-DeMarco MA, Konel J, Warsame F, Ying H, González Fernández M, Carlson MC, Fine DM, Appel LJ, Segev DL. Intradialytic Cognitive and Exercise Training May Preserve Cognitive Function. Kidney Int Rep. 2017; 3(1):81-88. PMCID: PMC5762950.